Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127619952 | 12761995 | 2 | F | 20160916 | 20160920 | 20160922 | EXP | JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2016RR-124208 | RANBAXY | 69.00 | YR | M | Y | 0.00000 | 20160922 | OT | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127619952 | 12761995 | 1 | PS | RISPERIDONE. | RISPERIDONE | 1 | Unknown | 0.5 MG, DAY 0-29 | Y | U | 0 | .5 | MG | ||||||
| 127619952 | 12761995 | 2 | SS | Zopiclone | ZOPICLONE | 1 | Unknown | 7.5 MG, UNK | Y | U | 0 | 7.5 | MG | ||||||
| 127619952 | 12761995 | 3 | C | Sodium valproate | VALPROATE SODIUM | 1 | Unknown | 600 MG, DAY 0-39 | Y | U | 0 | 600 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127619952 | 12761995 | 1 | Treatment noncompliance |
| 127619952 | 12761995 | 2 | Treatment noncompliance |
| 127619952 | 12761995 | 3 | Treatment noncompliance |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127619952 | 12761995 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127619952 | 12761995 | Condition aggravated | |
| 127619952 | 12761995 | Extrapyramidal disorder |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |